{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/26/3351560/34323/en/jama-dermatology-publishes-skin-specific-outcomes-from-phase-3-valor-trial-of-brepocitinib-in-dermatomyositis.html", "message": "News view counter 903305 successfully enlarged"}